Your browser doesn't support javascript.
loading
Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
Zhang, Yuemiao; Ma, Xupu; Yan, Guanghong; Wu, Ying; Chen, Yanli; Zhou, Zumi; Wan, Na; Su, Wei; Liu, Feng-Wei; Dai, Mu-Xian; Yang, Mei; Li, Chunmei; Yu, Xuanjing; Zhang, Liang; Wang, Zhongfang; Zhou, Tai-Cheng; You, Dingyun; Wei, Jia; Zhang, Zijie.
Afiliação
  • Zhang Y; State Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China.
  • Ma X; Renal Division, Department of Medicine, Peking University First Hospital, Renal Pathology Center, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China; Research Units o
  • Yan G; State Key Laboratory of Genetic Resources and Evolution, and Yunnan Laboratory of Molecular Biology of Domestic Animals, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223 and College of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China.
  • Wu Y; State Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China.
  • Chen Y; School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
  • Zhou Z; Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Biostatistics, School of Public Health, Southern Medical University, Guangdong, China.
  • Wan N; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan, People's Republic of China.
  • Su W; State Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China.
  • Liu FW; Yunnan Genvoo Biotech Ltd., Kunming, Yunnan, People's Republic of China.
  • Dai MX; State Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China.
  • Yang M; State Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China.
  • Li C; Yunnan Genvoo Biotech Ltd., Kunming, Yunnan, People's Republic of China.
  • Yu X; Central Lab, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan 650091, China.
  • Zhang L; Central Lab, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan 650091, China.
  • Wang Z; State Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China.
  • Zhou TC; State Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China.
  • You D; State Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China.
  • Wei J; State Key Laboratory of Genetic Resources and Evolution, and Yunnan Laboratory of Molecular Biology of Domestic Animals, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223 and College of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China.
  • Zhang Z; Yunnan Genvoo Biotech Ltd., Kunming, Yunnan, People's Republic of China.
EClinicalMedicine ; 54: 101680, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36188435
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: EClinicalMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: EClinicalMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China